GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Total Equity

IMGT (XKRX:456570) Total Equity : ₩-16,857.41 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Total Equity?

IMGT's total equity for the quarter that ended in Dec. 2023 was ₩-16,857.41 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


IMGT Total Equity Historical Data

The historical data trend for IMGT's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Total Equity Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Equity
-12,399.77 -28,248.96 -27,035.15 -16,857.41

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Total Equity -12,399.77 -28,248.96 -27,035.15 -16,857.41

IMGT Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

IMGT's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=10559.766-27417.176
=-16,857.41

IMGT's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=10559.766-27417.176
=-16,857.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMGT Total Equity Related Terms

Thank you for viewing the detailed overview of IMGT's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


IMGT Business Description

Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT Headlines

No Headlines